Sophia J. Langlois insider trades
Open-market stock purchases and sales by Sophia J. Langlois, Director at Keenova Therapeutics plc, from SEC Form 4 filings since Jun 2, 2026.
Companies traded
- NONE Keenova Therapeutics plc: other filings, last Jun 2, 2026